ROR2 promotes cell cycle progression and cell proliferation through the PI3K/AKT signaling pathway in gastric cancer
Molecular Carcinogenesis · 2024
DOI: 10.1002/mc.23811 ↗At a glance
Journal article in Molecular Carcinogenesis, 2024. Written by Qi Liu and 5 co-authors. Institution: Medical Research and Laboratory Diagnostic Center, Jinan Central Hospital, Shandong University, Jinan, China. Major MEDLINE topics: Stomach Neoplasms, Receptor Tyrosine Kinase-like Orphan Receptors, Cell Proliferation, Proto-Oncogene Proteins c-akt. Cited 2 times so far (Crossref); 47 references. Funded by: Clinical Multicenter Application of Biological High-Performance Computing for Precision Medicine, Establishment of a soluble GCD59 detection system and its clinical value in diabetic nephropathy.
Abstract (original language)
Proliferation is a critical characteristic of the progression of gastric cancer (GC). Receptor tyrosine kinase‐like orphan receptor 2 (ROR2), the orphan receptor tyrosine kinase‐like receptor, exhibits effects on tumor growth due to its abnormal expression in cancer. The goal of our study was to assess the potential regulatory role exerted by the ROR2 on GC cells. Through previous bioinformatics analysis, we discovered an association between ROR2 and the G2/M phase of the GC cell cycle. However, little is known about the link between ROR2 and the G2/M phase cell cycle in GC. Here, the findings of our study indicate that ROR2, after transcribed expression by Twist1, activates the PI3K/AKT/mTOR/S6K signal transduction pathway, thus leading to the acceleration of the G2/M phase and subsequent promotion of cell proliferation in GC. Furthermore, the functional link among ROR2, Twist1, and G2/M phase of cell cycle was also confirmed in mouse xenograft tissues and human tissues. ROR2 expression was correlated with Twist expression and lower survival in vivo. Notably, our suggestion is that focusing on ROR2 as a potential therapeutic approach could show potential for the management of GC.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Medical Research and Laboratory Diagnostic Center, Jinan Central Hospital, Shandong University, Jinan, China.
- Medical Research and Laboratory Diagnostic Center, Jinan Central Hospital Affiliated to Shandong First Medical University, Jinan, China.
ORCID profiles: Shuyi Han
Funding
- Clinical Multicenter Application of Biological High-Performance Computing for Precision Medicine
- Establishment of a soluble GCD59 detection system and its clinical value in diabetic nephropathy
Cite
APA
Liu, Q., Zhao, X., Shao, X., Cheng, P., Cui, J., & Han, S. (2024). ROR2 promotes cell cycle progression and cell proliferation through the PI3K/AKT signaling pathway in gastric cancer. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23811
Vancouver
Liu Q, Zhao X, Shao X, Cheng P, Cui J, Han S. ROR2 promotes cell cycle progression and cell proliferation through the PI3K/AKT signaling pathway in gastric cancer. Molecular Carcinogenesis. 2024. doi:10.1002/mc.23811
BibTeX
@article{Liu2024,
author = {Liu, Qi and Zhao, Xin and Shao, Xiaowen and Cheng, Ping and Cui, Jingyi and Han, Shuyi},
title = {ROR2 promotes cell cycle progression and cell proliferation through the PI3K/AKT signaling pathway in gastric cancer},
journal = {Molecular Carcinogenesis},
year = {2024},
doi = {10.1002/mc.23811}
}
EUVIMED